more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

Top 28% (71 out of 250)

Industry: Medical - Products

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

What's in Store for Edwards Lifesciences' (EW) Q3 Earnings?

by Zacks Equity Research Published on October 14,2020

Robust customer adoption of the TruWave disposable pressure monitoring devices and the INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q3 revenues.

Why Abbott (ABT) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research Published on October 13,2020

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ABTPositive Net Change

The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle

by Zacks Equity Research Published on October 13,2020

The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle

Abbott's New Antibody Test Gets FDA's EUA, Test Suite Expands

by Zacks Equity Research Published on October 13,2020

Abbott's (ABT) latest antibody test is expected to give a clearer picture of the rate of recovery post coronavirus infection.

medical

Here's Why Momentum Investors Will Love Abbott (ABT)

by Zacks Equity Research Published on October 12,2020

Does Abbott (ABT) have what it takes to be a top stock pick for momentum investors? Let's find out.

ABTPositive Net Change

Abbott (ABT) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research Published on October 12,2020

Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ABTPositive Net Change

Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research Published on October 12,2020

Is (ABT) Outperforming Other Medical Stocks This Year?

ABTPositive Net Change

Abbott's Data From Interim Clinical Study of ID NOW Positive

by Zacks Equity Research Published on October 12,2020

Abbott's (ABT) recent data from an interim clinical study on its ID NOW COVID-19 rapid test reflects the test's capacity to deliver effective, consistent and reliable performance.

medical

Top Research Reports for Visa, Walmart & Abbott

by Sheraz Mian Published on October 12,2020

Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Walmart (WMT) and Abbott Laboratories (ABT).

3 Large-Cap MedTech Growth Stocks to Buy Amid the Pandemic

by Sriparna Ghosal Published on October 09,2020

Let's take a look at three large-cap MedTech stocks that are currently flourishing on the back of a number of positive developments.

medical

Coronavirus Drives Testing Stocks: Is There Room for More Upside?

by Urmimala Biswas Published on October 06,2020

Given the current testing requirements across the world, the diagnostic testing business for COVID-19 is rapidly evolving.

medical

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research Published on October 05,2020

Abbott (ABT) closed the most recent trading day at $108.56, moving +1.93% from the previous trading session.

ABTPositive Net Change

Masimo's (MASI) Rad-G Pulse Oximeter Receives FDA Clearance

by Zacks Equity Research Published on October 02,2020

Masimo's (MASI) Rad-G Pulse Oximeter receives FDA clearance, thereby allowing clinicians to access the most accurate and reliable pulse oximetry monitoring technologies.

Abbott's Libre 3 Receives CE Mark, Boosts CGM Prospects

by Zacks Equity Research Published on October 02,2020

Abbott's (ABT) environment-friendly next-generation FreeStyle Libre 3 system aims to provide a better quality of life to diabetics in Europe at the same affordable price of previous systems.

3 Beaten-Down MedTech Stocks to Grab Amid Market Meltdown

by Sriparna Ghosal Published on October 01,2020

These cheap MedTech stocks are currently flourishing on the back of a number of positive developments.

medical

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research Published on September 29,2020

Abbott (ABT) closed at $105.19 in the latest trading session, marking a +0.72% move from the prior day.

ABTPositive Net Change

3 Great MedTech Stocks to Pick Amid the Coronavirus Crisis

by Sriparna Ghosal Published on September 25,2020

Backed by projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.

medical

Abbott's MitraClip G4 Receives CE Mark for Treatment of MR

by Zacks Equity Research Published on September 24,2020

Abbott's (ABT) MitraClip G4 is expected to improve MR patients' quality of life post its usage eligibility in Europe and other countries recognizing the CE Mark.